Published in J Clin Microbiol on July 01, 1984
Rapid detection of bacteremia in children with a modified lysis direct plating method. J Clin Microbiol (1985) 1.12
Improved recovery of antibiotic-stressed microorganisms on inclusion of saponin in aerobic blood culture media. Eur J Clin Microbiol Infect Dis (1998) 0.78
Poor performance of BACTEC NR 730 blood culture system in early detection of Neisseria meningitidis. J Clin Microbiol (1989) 0.78
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Effect of sodium polyanethol sulfonate in blood cultures. J Clin Microbiol (1975) 4.90
Inhibitory effect in vitro of sodium polyanethol sulfonate on the growth of Neisseria meningitidis. J Clin Microbiol (1975) 3.06
Anticomplementary, anticoagulatory, and serum-protein precipitating activity of sodium polyanetholsulfonate. Appl Microbiol (1970) 2.96
Gelatin neutralization of the inhibitory effect of sodium polyanethol sulfonate on Neisseria meningitidis in blood culture media. J Clin Microbiol (1977) 2.16
Inhibition of Neisseria gonorrhoeae by sodium polyanetholesulfonate. J Clin Microbiol (1981) 1.43
Inactivation of the polyanionic detergent sodium polyanetholsulfonate by hemoglobin. J Clin Microbiol (1983) 1.33
Enhancement of recovery of Neisseria meningitidis by gelatin in blood culture media. J Clin Microbiol (1981) 1.12
A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med (1990) 4.46
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00
Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol (1993) 2.85
Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med (1995) 2.74
Polymerase chain reaction-based restriction fragment length polymorphism analysis of a fragment of the ribosomal operon from Rochalimaea species for subtyping. J Clin Microbiol (1993) 2.41
Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother (1979) 2.40
Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis. J Clin Microbiol (1980) 2.24
Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23
Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20
Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med (1992) 2.20
Relationship between superoxide dismutase and pathogenic mechanisms of Listeria monocytogenes. Infect Immun (1979) 2.15
Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med (1997) 1.79
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother (1982) 1.74
Comparison of sedimentation and flotation techniques for identification of Cryptosporidium sp. oocysts in a large outbreak of human diarrhea. J Clin Microbiol (1985) 1.73
The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med (1991) 1.72
Evaluation of a lysis direct plating method for pediatric blood cultures. J Clin Microbiol (1985) 1.61
Experimental infection of young specific pathogen-free cats with Bartonella henselae. J Infect Dis (1997) 1.61
Evaluation of Bactogen and Phadebact for detection of Haemophilus influenzae type b antigen in cerebrospinal fluid. J Clin Microbiol (1982) 1.50
In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum. Antimicrob Agents Chemother (1985) 1.42
Evaluation of the Phadebact CSF test for detection of the four most common causes of bacterial meningitis. J Clin Microbiol (1983) 1.40
Septicemia and meningitis caused by Helicobacter cinaedi in a neonate. J Clin Microbiol (1993) 1.39
Murine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana. J Clin Microbiol (1992) 1.34
Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrob Agents Chemother (1980) 1.30
In vitro activity of BMY-28100 against common isolates from pediatric infections. Antimicrob Agents Chemother (1987) 1.26
Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group. J Infect Dis (1993) 1.24
Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol (1994) 1.23
Is Clostridium difficile pathogenic in infants? J Pediatr (1982) 1.19
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother (1981) 1.17
Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol (1992) 1.12
In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother (1985) 1.12
Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea. Antimicrob Agents Chemother (1986) 1.11
Evidence of reproductive failure and lack of perinatal transmission of Bartonella henselae in experimentally infected cats. Vet Immunol Immunopathol (1998) 1.08
Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis. Antimicrob Agents Chemother (1982) 1.07
In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob Agents Chemother (1982) 1.07
Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test. J Clin Microbiol (1982) 1.06
Pneumonia caused by a newly recognized pseudomonad in a child with chronic granulomatous disease. J Clin Microbiol (1990) 1.00
Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 0.99
Fasle-positive macroscopic appearance of blood cultures in sorbitol-containing hypertonic medium. J Clin Microbiol (1979) 0.98
Moxalactam therapy of Haemophilus influenzae type b meningitis in children. J Pediatr (1984) 0.96
Recognition of Staphylococcus saprophyticus in urine cultures by screening colonies for production of phosphatase. J Clin Microbiol (1985) 0.96
Cat scratch disease: the rare role of Afipia felis. J Clin Microbiol (1998) 0.94
A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis. Pediatr Pharmacol (New York) (1985) 0.93
Comparison of lysis-direct plating and broth methods for pediatric blood cultures: clinical relevance and cost effectiveness. Pediatr Infect Dis (1985) 0.92
Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis (1986) 0.92
Sputum screening by Nomarski interference contrast microscopy. J Clin Microbiol (1979) 0.91
Campylobacter enteritis. A 3-year experience. Clin Pediatr (Phila) (1984) 0.91
Synergistic action of amphotericin B and rifampin against Rhizopus species. Antimicrob Agents Chemother (1987) 0.90
Catalase-negative listeria monocytogenes causing meningitis in an adult. Clinical and laboratory features. Am J Clin Pathol (1991) 0.89
Evaluation of the automated Bact-Alert system for pediatric blood culturing. Am J Clin Pathol (1995) 0.88
Morphologically variable bacilli of cat scratch disease are identified by immunocytochemical labeling with antibodies to Rochalimaea henselae. Am J Clin Pathol (1994) 0.86
Immune response of neonatal specific pathogen-free cats to experimental infection with Bartonella henselae. Vet Immunol Immunopathol (1999) 0.85
Evaluation of an enzyme immunoassay for detection of Neisseria gonorrhoeae in an adolescent population. JAMA (1984) 0.84
Diagnosis of bacterial infections of the newborn infant. Clin Perinatol (1981) 0.84
Middle ear effusion amoxicillin concentrations in acute otitis media. Pediatr Infect Dis J (1998) 0.83
In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Antimicrob Agents Chemother (1984) 0.82
In vitro activity of ciprofloxacin against pediatric pathogens. Chemotherapy (1985) 0.80
Suppurative infections in children caused by non-beta-hemolytic members of the Streptococcus milleri group. Pediatr Infect Dis J (1995) 0.80
Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations. Antimicrob Agents Chemother (1982) 0.80
Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics. Antimicrob Agents Chemother (1983) 0.80
Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin. Clin Ther (1980) 0.80
In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin. Chemotherapy (1982) 0.77
Cefoperazone pharmacokinetics in acute childhood meningitis. J Pediatr (1983) 0.77
Protozoal colonization of the intestinal tract in institutionalized Romanian children. Clin Infect Dis (1996) 0.76
Aeromonas species in aquaria: a reservoir of gastrointestinal infections? J Hosp Infect (1989) 0.76
Fiber-bundle coupled, diode end-pumped Nd:YAG laser. Opt Lett (1988) 0.75
Serratia osteochondritis after puncture wounds of the foot. Pediatr Infect Dis J (1990) 0.75
Enoxacin pharmacokinetics and efficacy in CF-1 mice. J Antimicrob Chemother (1987) 0.75
Use of preserved organisms for individual test-use quality control of bacterial typing antisera. J Clin Microbiol (1980) 0.75
Ultrahigh-power semiconductor diode laser arrays. Science (1987) 0.75
Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia. J Antimicrob Chemother (1985) 0.75
12.5-W continuous-wave monolithic laser-diode arrays. Opt Lett (1988) 0.75
Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae. Chemotherapy (1989) 0.75
Broadly tunable laser-diode-based mid-infrared source with up to 31 microW of power at 4.3-microm wavelength. Opt Lett (1996) 0.75
Modal analysis of linear Talbot-cavity semiconductor lasers. Opt Lett (1991) 0.75
Neonatal sepsis and meningitis due to alpha-hemolytic Streptococcus. South Med J (1983) 0.75
Automated phase sensing and control of an external Talbot cavity laser with phase-contrast imaging. Appl Opt (1994) 0.75